EBS EBITDA
-$700.00KTTM · USD
Period ending:
EBS FY EBITDAUSD
$613.70M-$43.00M
2001-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
EBS ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 237,900,000 | |
| 56,600,000 | |
| -43,000,000 | |
| 34,000,000 | |
| 509,800,000 | |
| 613,700,000 | |
| 261,600,000 | |
| 155,100,000 | |
| 174,700,000 | |
| 132,900,000 | |
| 186,676,000 | |
| 121,641,000 | |
| 65,060,000 | |
| 47,759,000 | |
| 41,298,000 | |
| 79,356,000 | |
| 46,517,000 | |
| 37,024,000 | |
| 37,910,000 | |
| 43,882,000 | |
| 25,425,000 | |
| 18,709,000 | |
| 55,769,000 | |
| 37,767,000 | |
| 45,309,000 |
Compare ebitda
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) ebitda
- Bridgebio Pharma Inc (BBIO) ebitda
- Brightspring Health Services Inc (BTSG) ebitda
- Madrigal Pharmaceuticals Inc (MDGL) ebitda
- Ensign Group Inc (ENSG) ebitda
- Glaukos Corp (GKOS) ebitda
- Vaxcyte Inc (PCVX) ebitda
- Krystal Biotech Inc (KRYS) ebitda
All EBS financial metrics · EBS stock overview · How to interpret financial metrics
